about
Synergizing vaccinations with therapeutics for measles eradicationStructure of the Ulster Strain Newcastle Disease Virus Hemagglutinin-Neuraminidase Reveals Auto-Inhibitory Interactions Associated with Low VirulenceExtensive Mutagenesis of the HSV-1 gB Ectodomain Reveals Remarkable Stability of Its Postfusion FormStructure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome CoronavirusCrystal Structures of Beta- and Gammaretrovirus Fusion Proteins Reveal a Role for Electrostatic Stapling in Viral EntryFusion of Enveloped Viruses in Endosomes.Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric poreProteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.Detection and sequence/structure mapping of biophysical constraints to protein variation in saturated mutational libraries and protein sequence alignments with a dedicated serverA direct and versatile assay measuring membrane penetration of adenovirus in single cells.Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.Efficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain.Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathwayFunctional fluorescent protein insertions in herpes simplex virus gB report on gB conformation before and after execution of membrane fusion.Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion.Broad-spectrum antivirals against viral fusion.Structure of the primed paramyxovirus fusion protein.Triggering the measles virus membrane fusion machinery.Retrovirus entry by endocytosis and cathepsin proteases.Envelope protein dynamics in paramyxovirus entry.Unraveling the entry mechanism of baculoviruses and its evolutionary implications.Filovirus entry: a novelty in the viral fusion world.Lipids in innate antiviral defense.Viruses exploit the function of epidermal growth factor receptor.Inhibition of endocytic pathways impacts cytomegalovirus maturation.Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusionA stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion.Structure and organization of paramyxovirus particles.IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.Intracellular trafficking of begomoviruses in the midgut cells of their insect vector.Single-Domain Antibodies As Therapeutics against Human Viral Diseases.
P2860
Q27003149-74AF95B8-BD64-4C9E-A500-E064D4C82BA9Q27671654-BB1A0FB0-518F-489C-93AB-C5B91D0CED71Q27676847-859C81AC-60D7-4587-AFBF-3743299F789CQ27680061-600DD352-EAD7-421C-857D-4D0E989C3ED0Q27680387-4C5E5AF1-4042-4922-AF82-6EBB8144DB7DQ28073406-F4CBAEC4-033F-497B-9076-2CAD630B59A5Q28541727-1357F479-3289-47A1-92D4-7D68B960C3F0Q30354466-2534536A-8315-4883-AF55-EEC63E81421EQ30389475-D6F4E623-11A0-4373-A7D2-FF48B271A98FQ30413406-59CCAEDB-8F37-4DC6-A410-22ED27BB904EQ34082711-2AA6B47A-71D0-4876-8638-F13D4383D3A2Q34583532-DFFECE0F-082F-4E34-A4C1-0804D398B209Q34992782-0EB2B08E-9F08-4700-B20F-81C26800D1AAQ35261990-9819E2A0-7C28-4EAB-BDDE-AEB28C77AF61Q35399141-C74AF892-39EC-4172-B36B-D0B4E8EF3D67Q35956606-0066DF39-761D-4C9D-A6B7-3E81643F9EC1Q36010083-48059B9D-002B-41E3-B5D9-04705693D4AEQ36340035-027CF3B6-286B-4525-B402-BE0310871C5BQ36397970-CA14F77A-4203-4FAB-90E1-18B6E462BA3DQ36469011-E519F9A7-B6F7-46AC-95FB-6BECC662DB09Q36994390-901D207D-1DC9-4947-B3FE-CB0F6E5791EEQ37547133-9DDA9B76-9E91-4A33-8C6A-8169711AB52FQ37999360-102B9D0E-02CF-4BAA-879C-FC17E314C6F5Q38153910-6AD1DF30-248A-4426-B758-B4FE36DF6247Q38216860-2B573E39-2A6E-4A7B-98E1-AAB951190391Q38838830-0649A8E9-363D-41B5-B754-44B678FC787AQ38940842-A1D65642-D41C-4A23-A118-8900E55E7EDDQ39106872-C6BF93D4-A376-43C3-9626-2012F1F32CE5Q39364461-DF536122-9552-4FA7-AE5E-9DB1A8080318Q40181638-3FD42847-A2D6-4A2F-B137-47507F18DB11Q41928655-BD3EF3CA-34A5-44BD-BF70-10D84A073A11Q47548913-873E07C3-118C-4D6D-ABE2-7365D8C18E1FQ47554821-7A25AA55-2B71-4D51-8597-60877B9A09F4
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Cell entry of enveloped viruses
@ast
Cell entry of enveloped viruses
@en
Cell entry of enveloped viruses
@nl
type
label
Cell entry of enveloped viruses
@ast
Cell entry of enveloped viruses
@en
Cell entry of enveloped viruses
@nl
prefLabel
Cell entry of enveloped viruses
@ast
Cell entry of enveloped viruses
@en
Cell entry of enveloped viruses
@nl
P2860
P3181
P1476
Cell entry of enveloped viruses
@en
P2093
Richard K Plemper
P2860
P304
P3181
P356
10.1016/J.COVIRO.2011.06.002
P407
P577
2011-08-01T00:00:00Z